MétaCan
Menu
← Back to cohort
Record W4311268033 · doi:10.21203/rs.3.rs-2312251/v1

A MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting

2022· preprint· en· W4311268033 on OpenAlexaff
Silvia Pomella, Matteo Cassandri, Cristina Cossetti, Doris A. Phelps, Clara Perrone, Michele Pezzella, Antonella Cardinale, Marco Wachtel, Marta Colletti, Zoë S. Walters, Prethish Sreeni, Di Giannatale Angela, Giuseppe Maria Milano, Francesco Marampon, Cristiano De Stefanis, Rita Alaggio, Sonia Rodrı́guez, Nadia Carlesso, Christopher R. Vakoc, Enrico Velardi, Beat W. Schäfer, Ernesto Guccione, Susanne A. Gatz, Ajla Wasti, Marielle E. Yohe, Javed Khan, Myron S. Ignatius, Concetta Quintarelli, Janet Shipley, Lucio Miele, Peter J. Houghton, Berkley E. Gryder, Biagio De Angelis, Franco Locatelli, Rossella Rota

Bibliographic record

VenueResearch Square · 2022
Typepreprint
Languageen
FieldMedicine
TopicSarcoma Diagnosis and Treatment
Canadian institutionsInstitute of Cancer Research
FundersInstitute of Molecular and Cell BiologyAlleanza Contro il CancroUniversità degli Studi Roma TreAgency for Science, Technology and ResearchAssociazione Italiana per la Ricerca sul CancroMinistero della SaluteMinistero dell’Istruzione, dell’Università e della Ricerca
KeywordsMyoDCancer researchSKP2CarcinogenesisFusion proteinRhabdomyosarcomaBiologyMedicineCell biologyInternal medicinePathologyCancerMyogenesisGeneticsMyocyteSarcomaUbiquitinRecombinant DNAUbiquitin ligase

Abstract

fetched live from OpenAlex

Abstract Rhabdomyosarcoma (RMS) is a pediatric mesenchymal-derived malignancy encompassing Fusion Positive (FP)-RMS expressing PAX3/7-FOXO1 and Fusion Negative (FN)-RMS often mutated in the RAS pathway. RMS expresses the master myogenic transcription factor MYOD that, paradoxically, in the tumor context is essential for tumor cell growth and survival. We identify here SKP2, an oncogenic E3-ubiquitin ligase of the SCF/CRL1 complex, as a critical driver of tumorigenesis downstream of MYOD in FN-RMS. SKP2 is overexpressed in RMS at the highest levels among several adult and pediatric cancers and its expression is maintained by MYOD through an intronic enhancer within the gene, in loop with its promoter. Mechanistically, in FN-RMS cells SKP2 functions by directly targeting p27Kip1 and p57Kip2 promoting their degradation. SKP2 knockdown causes cell cycle arrest by enhancing p27Kip1 and promotes differentiation by increasing p57Kip2, which in turn stabilizes MYOD. This leads to MYOD and MYOG increase and unlocks a myogenic program resulting in de novo expression of terminal muscle differentiation markers and cell fusion. SKP2 depletion strongly affects stemness and anchorage-independence features and prevents tumor growth. The investigational NEDDylation inhibitor MLN4924 (Pevonedistat) hampers SKP2 functions restraining FN-RMS cell survival and tumor growth. Our results uncover a MYOD-SKP2 axis crucial for the crosstalk between transcriptional and post-translational mechanisms that contribute to FN-RMS tumorigenesis and broaden the understanding of MYOD function. Furthermore, they suggest inhibition of NEDDylation as a potential therapeutic approach in this tumor.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.391
Teacher spread0.335 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueResearch Square→Same topicSarcoma Diagnosis and Treatment→French-language works237,207→